SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: NEWS RELEASEystar Bio-Pharmaceutical Reports 27% Growth in Revenue
[NEWS RELEASEystar Bio-Pharmaceutical Reports 27% Growth in Revenue Fromntinuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidancereased to $45.5 Million to $47.5 Million XIAN, CHINA May 18, 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"),]